Home >> Marketplace Archives >> Agilent acquires ProZyme, Ultra Scientific

Agilent acquires ProZyme, Ultra Scientific

Print Friendly, PDF & Email

September 2018—Agilent Technologies has entered into a definitive agreement to acquire ProZyme, a provider of glycan analysis reagents, kits, and standards. The acquisition will expand Agilent’s portfolio of biopharma consumables.

In a separate release, Agilent announced it has completed the acquisition of Ultra Scientific, a provider of chemical standards and certified reference materials.

Agilent Technologies, 408-345-8886


Check Also

FDA expands use of Agilent CDx

Sept. 28, 2017—Agilent Technologies announced that the FDA has approved the cancer diagnostic PD-L1 IHC...